The rate of MEFV gene mutations in hematolymphoid neoplasms

International Journal of Immunogenetics

Volumn 37, Issue 5, 2010, Pages 387-391

  Celik, S ^a   Erikci, A A ^a   Tunca, Y ^b   Sayan, O ^a   Terekeci, H M ^a   Umur, E E ^a   Torun, D ^b   Tangi, F ^a   Top, C ^a   Oktenli, C ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC DIFFERENCE; GENETIC SUSCEPTIBILITY; HEMATOLOGIC MALIGNANCY; HEMATOLYMPHOID NEOPLASM; HETEROZYGOTE; HUMAN; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE MEFV; PRIORITY JOURNAL;

ADULT; AGED; CYTOSKELETAL PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION; YOUNG ADULT;

EID: 78651100900     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2010.00938.x     Document Type: Article

References (52)

1. Annunziata, C.M., Davis, R.E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F. et al. (2007) Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell, 12, 115.
2. Apte, R.N. & Voronov, E. (2008) Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunological Reviews, 222, 222.
3. Apte, R.N., Dotan, S., Elkabets, M., White, M.R., Reich, E., Carmi, Y. et al. (2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Reviews, 25, 387.
4. Bertin, J. & DiStefano, P.S. (2000) The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differentiation, 7, 1273.
5. Bottero, V., Withoff, S. & Verma, I.M. (2006) NF-κB and the regulation of hematopoiesis. Cell Death and Differentiation, 13, 785.
6. Centola, M., Aksentijevich, I. & Kastner, D.L. (1998) The hereditary periodic fever syndromes: Molecular analysis of a new family of inflammatory diseases. Human Molecular Genetics, 7, 1581.
7. Cerretti, D.P., Kozlosky, C.J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T.A. et al. (1992) Molecular cloning of the interleukin-1β converting enzyme. Science, 256, 97.
8. Chae, J.J., Wood, G., Richard, K., Jaffe, H., Colburn, N., Masters, S.L. et al. (2008) The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-κB through its N-terminal fragment. Blood, 112, 1794.
9. Chen, F., Beezhold, K. & Castranova, V. (2008) Tumor promoting or tumor suppressing of NF-κB, a matter of cell context dependency. International Reviews of Immunology, 27, 183.
10. Cheng, J., Waite, A.L., Tkaczyk, E.R., Ke, K., Richards, N., Hunt, A.J. et al. (2010) Kinetic properties of ASC protein aggregation in epithelial cells. Journal of Cellular Physiology, 222, 738.
11. Conway, K.E., McConnell, B.B., Bowring, C.E., Donald, C.D., Warren, S.T. & Vertino, P.M. (2000) TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Research, 60, 6236.
12. Demirkaya, E., Tunca, Y., Gok, F., Ozen, S. & Gul, D. (2008) A very frequent mutation and remarkable association of R761H with M694V mutations in Turkish familial Mediterranean fever patients. Clinical Rheumatology, 27, 729.
13. Diaz, A., Hu, C., Kastner, D.L., Schaner, P., Reginato, A.M., Richards, N. et al. (2004) Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts: A prominent splice isoform lacks theC-terminal domain that is highly mutated in familial Mediterranean fever. Arthritis Rheumatism, 50, 3679.
14. Fairbrother, W.J., Gordon, N.C., Humke, E.W., O'Rourke, K.M., Starovasnik, M.A., Yin, J.P. et al. (2001) The PYRIN domain: a member of the death domain-fold superfamily. Protein Science, 10, 1911.
15. Fernandes-Alnemri, T., Wu, J., Yu, J.W., Datta, P., Miller, B., Jankowski, W. et al. (2007) The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differentiation, 14, 1590.
16. Grateau, G., Pecheux, C., Cazeneuve, C., Cattan, D., Dervichian, M., Goossens, M. et al. (2000) Clinical versus genetic diagnosis of familial Mediterranean fever. Quarterly Journal of Medicine, 93, 223.
17. Grossmann, M., Metcalf, D., Merryfull, J., Beg, A., Baltimore, D. & Gerondakis, S. (1999) The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects. Proceedings of the National Academy of Sciences, USA, 96, 11848.
18. Hallek, M., Bergsagel, P.L. & Anderson, K.C. (1998) Multiple myeloma: increasing evidence for a multistep transformation process. Blood, 91, 3.
19. Hanahan, D. & Weinberg, R.A. (2000) The hallmarks of cancer. Cell, 100, 57.
20. Karin, M. & Greten, F.R. (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nature Reviews Immunology, 5, 749.
21. Keats, J.J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.J. et al. (2007) Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell, 12, 131.
22. Keutgens, A., Robert, I., Viatour, P. & Chariot, A. (2006) Deregulated NF-κB activity in haematological malignancies. Biochemical Pharmacology, 72, 1069.
23. Koc, B., Oktenli, C., Bulucu, F., Karadurmus, N., Sanisoglu, S.Y. & Gul, D. (2007) The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study. Journal of Rheumatology, 34, 2070.
24. Kordes, U., Krappmann, D., Heissmeyer, V., Ludwig, W.D. & Scheidereit, C. (2000) Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia, 14, 399.
25. Lia, Z.W., Chena, H., Campbella, R.A., Bonavidab, B. & Berensona, J.R. (2008) NF-κB in the pathogenesis and treatment of multiple myeloma. Current Opinion in Hematology, 15, 391.
26. Liepinsh, E., Barbals, R., Dahl, E., Sharipo, A., Staub, E. & Otting, G. (2003) The death-domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition. Journal of Molecular Biology, 332, 1155.
27. Manji, GA, Wang, L, Geddes, BJ, Brown, M, Merriam, S, Al-Garawi, A et al. (2002) PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. Journal of Biological Chemistry, 277, 11570.
28. Martinon, F, Hofmann, K & Tschopp, J. (2001) The pyrin domain: a possible member of the death domainfold family implicated in apoptosis and inflammation. Current Biology, 11, R118.
29. Masumoto, J., Taniguchi, S., Ayukawa, K., Sarvotham, H., Kishino, T., Niikawa, N. et al. (1999) ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. Journal of Biological Chemistry, 274, 33835.
30. Matsushita, K., Takeoka, M., Sagara, J., Itano, N., Kurose, Y., Nakamura, A. et al. (2009) A Splice Variant of ASC Regulates IL-1β Release and Aggregates Differently fromIntact ASC. Mediators of Inflammation, 287387, 1.
31. McConnell, B.B. & Vertino, P.M. (2004) TMS1/ASC: the cancer connection. Apoptosis, 9, 5.
32. Medlej-Hashim, M., Serre, J.L., Corbani, S., Saab, O., Jalkh, N., Delague, V. et al. (2004) Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations. European Journal of Medical Genetics, 48, 412.
33. Musabak, U., Sengul, A., Oktenli, C., Pay, S, Yesilova, Z, Kenar, L et al. (2004) Does immune activation continue during an attack-free period in familial Mediterranean fever? Clinical and Experimental Immunology, 138, 526.
34. Papin, S., Cuenin, S., Agostini, L., Martinon, F., Werner, S., Beer, H.D. et al. (2007) The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1β processing. Cell Death Differentiation, 14, 1457.
35. Richards, N., Schaner, P., Diaz, A., Stuckey, J., Shelden, E., Wadhwa, A. et al. (2001) Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. Journal of Biological Chemistry, 276, 39320.
36. Schaner, P., Richards, N., Wadhwa, A., Aksentijevich, I., Kastner, D.L., Tucker, P. et al. (2001) Episodic evolution of pyrin in primates:human mutations recapitulate ancestral amino acid states. Nature Genetics, 27, 318.
37. Siebenlist, U., Brown, K. & Claudio, E. (2005) Control of lymphocyte development by nuclear factor-κB. Nature Reviews Immunology, 5, 435.
38. Srinivasula, S.M., Poyet, J.L., Razmara, M., Datta, P., Zhang, Z. & Alnemri, E.S. (2002) The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. Journal of Biological Chemistry, 277, 21119.
39. Stehlik, C., Fiorentino, L., Dorfleutner, A., Bruey, J.M., Ariza, E.M., Sagara, J. et al. (2002) The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. Journal of Experimental Medicine, 196, 1605.
40. Stoffel, A. (2005) The NF-κB signalling pathway: a therapeutic target in lymphoid malignancies. Expert Opinion on Therapeutic Targets, 9, 1045.
41. Stojanov, S. & Kastner, D.L. (2005) Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Current Opinion in Rheumatology, 17, 586.
42. Terekeci, H.M., Oktenli, C., Ozgurtas, T., Nalbant, S., Top, C., Celik, S. et al. (2008a) Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? Journal of Rheumatology, 35, 2024.
43. Terekeci, H.M., Ulusoy, E.R., Kucukarslan, N.M., Nalbant, S. & Oktenli, C. (2008b) Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters. Rheumatology International, 28, 1239.
44. The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nature Genetics, 17, 25.
45. The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell, 90, 797.
46. Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J. et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature, 356, 768.
47. Tidow, N., Chen, X., Muller, C., Kawano, S., Gombart, A.F., Fischel-Ghodsian, N. et al. (2000) Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood, 95, 1451.
48. Touitou, I. (2001) The spectrum of familial Mediterranean fever (FMF) mutations. European Journal of Human Genetics, 9, 473.
49. Voll, R.E., Jimi, E., Phillips, R.J., Barber, D.F., Rincon, M., Hayday, A.C. et al. (2000) NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity, 13, 677.
50. Wang, L., Manji, G.A., Grenier, J.M., Al-Garawi, A., Merriam, S., Lora, J.M. et al. (2002) PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. Journal of Biological Chemistry, 277, 29874.
51. Weber, C.H. & Vincenz, C. (2001) The death domain superfamily: a tale of two interfaces? Trends in Biochemical Sciences, 26, 475.
52. Yilmaz, E., Ozen, S., Balci, B., Duzova, A., Topaloglu, R., Besbas, N. et al. (2001) Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. European Journal of Human Genetics, 9, 553.